On Wednesday, the authorities said DNA evidence had linked Mr. Bundy, who was executed in 1989, to the murder of a ...

MiNK Therapeutics is making waves in the cell therapy landscape with its groundbreaking allogeneic invariant natural killer T ...

Preclinical research has shown that CAR T cells directed against the urokinase plasminogen activator receptor can attack both ...

Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today ...

MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore immune balance and treat ...

MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore immune balance ...

Strongest association found for genes involved in natural killer cell activationFindings suggest need for more refined, ...

Breathlessness, fatigue and having the urge to go when you don’t need the toilet, could be lesser-known symptoms of bowel ...

Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has ...

The Ides of March afflicted the healthcare sector in March. But some key winners also emerged and April is off to a better ...

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...

A new CAR T-cell therapy attacks supportive cells in the tumor microenvironment that bear the surface protein, uPAR.